IMMvention Therapeutix Revenue and Competitors
Estimated Revenue & Valuation
- IMMvention Therapeutix's estimated annual revenue is currently $1.2M per year.
- IMMvention Therapeutix's estimated revenue per employee is $77,500
- IMMvention Therapeutix's total funding is $7.1M.
Employee Data
- IMMvention Therapeutix has 15 Employees.
- IMMvention Therapeutix grew their employee count by -17% last year.
IMMvention Therapeutix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Board Director | Reveal Email/Phone |
2 | Head Medicinal Chemistry | Reveal Email/Phone |
IMMvention Therapeutix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.9M | 77 | 7% | N/A | N/A |
#2 | $6221.7M | 40140 | -4% | N/A | N/A |
#3 | $2M | 13 | 0% | N/A | N/A |
#4 | $0.8M | 5 | -55% | N/A | N/A |
#5 | $2.8M | 18 | 6% | $11.1M | N/A |
#6 | $1M | 13 | -41% | N/A | N/A |
#7 | $1.7M | 11 | 0% | N/A | N/A |
#8 | $0.6M | 4 | 0% | N/A | N/A |
#9 | $5.9M | 38 | -5% | N/A | N/A |
#10 | $6.8M | 44 | 7% | N/A | N/A |
What Is IMMvention Therapeutix?
Stealth-mode venture-funded company. Discovering and developing first-in-class novel small molecule pan-inflammasome inhibitors for treating inflammatory diseases.
keywords:N/A
$7.1M
Total Funding
15
Number of Employees
$1.2M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IMMvention Therapeutix News
2022-03-30 - Local executives use internships to promote diversity in life ...
The organization, called OpenDoors, is led by Anil Goyal, CEO of Immvention Therapeutix in Research Triangle Park, and Joe Ruiz,...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 15 | -42% | N/A |
#2 | $1.3M | 15 | 25% | N/A |
#3 | $2.3M | 15 | -6% | N/A |
#4 | $2M | 16 | -20% | N/A |
#5 | $3.5M | 16 | -11% | N/A |